Effects of Magnesium Oil Application on the Muscle Contractile Properties

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05339308

Acronym

MG-MCP2022

Enrollment

Registered

2022-04-21

Start date

2022-05-01

Completion date

2022-09-01

Last updated

2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Magnesium, Skeletal Muscle Contraction Properties

Keywords

Tensiomyography, Skeletal Muscle, Contractile Properties

Brief summary

This study will aim to investigate the effects of magnesium oil administration on skeletal muscle contractile properties.

Detailed description

Aim: This study will aim to investigate the effects of magnesium oil administration on skeletal muscle contractile properties (SMcp). Design: Randomized controlled study Participants: For this purpose, investigators will recruit 40 recreationally active and healthy adults of both sexes (18-35 years of age). Methods: The experimental leg (EXP) will receive the 10 sprays of magnesium oil (20 mg per spray) that will be topically applied to the skin covering the knee extensor muscles, whereas the control leg (CON) will receive 10 sprays of natural mineral-free oil. The vastus lateralis SMcp will be measured by using a tensiomyography (TMG) device before application (PRE) and after 10 (POST10), 20 (POST20), 30 (POST30), 40 (POST40), and 50 (POST50) minutes of application onset, respectively.

Interventions

OTHERMagnesium oil (BetterYou) dermal application

10 sprays (200 mg) of magnesium oil (BetterYou) will be applied to skin covering knee extensor muscles. The magnesium oil will be applied only once

OTHERPlacebo Control

Natural mineral-free oil (10 sprays) will be applied as the control condition. This will be done only once

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

The participants will not be informed about the actual study purpose, while the main investigator will be blinded to the EXP or CON oil administration

Intervention model description

Randomized controlled study

Eligibility

Sex/Gender

ALL

Age

18 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

* healthy, recreationally active adults, no history of neuromuscular and musculoskeletal diseases

Exclusion criteria

* if some of the criteria are not met

Design outcomes

Primary

Measure	Time frame	Description
Skeletal Muscle Contractile Properties	75 minutes	Skeletal muscle contractile properties will be measured by using tensiomyography device

Countries

Czechia, Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026